Barriers and Facilitators to Oral PrEP Use Among Transgender Women in New York City
| Autor: | Christine Tagliaferri Rael, Susan G. Sherman, Richard T. D'Aquila, Will Mellman, Michelle Martinez, Alex Carballo-Diéguez, Rebecca Giguere, George J. Greene, Caitlin MacCrate, Pablo K. Valente, Walter O. Bockting, Katherine H.A. Footer |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2018 |
| Předmět: |
Adult
Male medicine.medical_specialty Social Psychology Anti-HIV Agents Social Stigma Human immunodeficiency virus (HIV) HIV Infections medicine.disease_cause Transgender Persons Transgender women Article 03 medical and health sciences 0302 clinical medicine Acquired immunodeficiency syndrome (AIDS) medicine Humans 030212 general & internal medicine Qualitative Research 030505 public health Public health Emtricitabine Tenofovir Disoproxil Fumarate Drug Combination Public Health Environmental and Occupational Health Focus Groups medicine.disease Focus group Health psychology Infectious Diseases Family medicine Pill Female New York City Pre-Exposure Prophylaxis 0305 other medical science Psychology |
| Popis: | Transgender women may face a disparate risk for HIV/AIDS compared to other groups. In 2012, Truvada was approved for daily use as HIV pre-exposure prophylaxis (PrEP). However, there is a dearth of research about barriers and facilitators to PrEP in transgender women. This paper will shed light on transgender women living in New York City’s perceived and actual challenges to using PrEP and potential strategies to overcome them. After completing an initial screening process, four 90-minute focus groups were completed with N=18 transgender women. Participants were asked what they like and dislike about PrEP. Participants identified the following barriers: uncomfortable side effects, difficulty taking pills, stigma, exclusion of transgender women in advertising, and lack of research on transgender women and PrEP. Facilitators included: reducing pill size, increasing the types of available HIV prevention products, and conducting scientific studies to evaluate PrEP in transgender women. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|